561 studies found for:    "Bone cancer"
Show Display Options
Rank Status Study
1 Completed Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System
Conditions: Bone Cancer;   Bone Metastases;   Pain
Intervention: Device: ExAblate 2100
2 Recruiting Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma
Conditions: Bone Cancer;   Bone Metastases;   Pain
Interventions: Device: Exablate treatment;   Radiation: Radiation
3 Recruiting Genomic Analysis of Pediatric Bone Tumors
Condition: Bone Cancer
Intervention:
4 Completed Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma
Conditions: Localized Osteosarcoma;   Metastatic Osteosarcoma;   Osteoblastic Osteosarcoma;   Recurrent Osteosarcoma
Intervention: Other: laboratory biomarker analysis
5 Recruiting Cabozantinib-s-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
Conditions: Metastatic Ewing Sarcoma;   Metastatic Osteosarcoma;   Recurrent Ewing Sarcoma;   Recurrent Osteosarcoma;   Stage IVA Osteosarcoma;   Stage IVB Osteosarcoma
Interventions: Drug: Cabozantinib S-malate;   Other: Laboratory Biomarker Analysis
6 Completed Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma
Conditions: Metastatic Osteosarcoma;   Relapsed Osteosarcoma
Interventions: Drug: Sorafenib;   Drug: Everolimus
7 Completed Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children
Conditions: Osteosarcoma;   Localised High Grade Osteosarcoma of the Limbs
Interventions: Drug: Etoposide, Ifosfamide, Methotrexate;   Drug: Doxorubicin, Methotrexate
8 Completed Study of Blood Samples From Patients With Osteosarcoma
Conditions: Localized Osteosarcoma;   Metastatic Osteosarcoma;   Recurrent Osteosarcoma
Intervention: Other: laboratory biomarker analysis
9 Recruiting Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
Conditions: Childhood Osteosarcoma;   Metastatic Osteosarcoma;   Recurrent Osteosarcoma
Interventions: Biological: Denosumab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
10 Terminated Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma
Conditions: Osteosarcoma;   Paget's Disease;   Ewing Sarcoma
Intervention: Other: DCE-MRI, DW-MRI, MT-MRI, and CEST-MRI
11 Recruiting Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung
Conditions: Osteosarcoma;   Metastatic Osteosarcoma
Intervention: Drug: pazopanib
12 Recruiting Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Condition: Metastatic Osteosarcoma
Interventions: Drug: Sm-EDTMP;   Other: Autologous Stem Cell Infusion;   Radiation: External Beam Radiotherapy
13 Recruiting Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma
Conditions: Metastatic Malignant Neoplasm in the Lung;   Metastatic Osteosarcoma;   Recurrent Osteosarcoma
Interventions: Biological: Dinutuximab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Biological: Sargramostim
14 Active, not recruiting Study of Denosumab in Subjects With Giant Cell Tumor of Bone
Conditions: Cancer;   GCT;   Giant Cell Tumor of Bone;   Benign GCT
Intervention: Drug: Denosumab
15 Active, not recruiting Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
Conditions: Localized Osteosarcoma;   Metastatic Osteosarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: cisplatin;   Drug: methotrexate;   Procedure: therapeutic conventional surgery;   Biological: peginterferon alfa-2b;   Drug: ifosfamide;   Drug: etoposide;   Procedure: quality-of-life assessment;   Other: questionnaire administration
16 Completed Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Ifosfamide, Carboplatin, Doxorubicin;   Procedure: Limb Sparing
17 Terminated A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response
Conditions: Osteosarcoma;   Lung Metastases
Interventions: Drug: Dexrazoxane;   Drug: Doxorubicin;   Drug: Cisplatin;   Drug: G-CSF;   Drug: PEG-filgrastim;   Drug: Etoposide;   Drug: Ifosfamide;   Drug: Mesna;   Drug: Leucovorin
18 Completed Phase II Study of Intravenous Rexin-G in Osteosarcoma
Condition: Osteosarcoma
Interventions: Genetic: Rexin-G Dose 1;   Genetic: Rexin-G Dose 2
19 Unknown  Diffusion Study on Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention:
20 Recruiting Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy
Conditions: Osteosarcoma;   Metastasis
Intervention: Drug: apatinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years